Susquehanna Fundamental Investments LLC Invests $1.62 Million in Addus HomeCare Co. (NASDAQ:ADUS)

Susquehanna Fundamental Investments LLC bought a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 13,989 shares of the company’s stock, valued at approximately $1,624,000. Susquehanna Fundamental Investments LLC owned approximately 0.08% of Addus HomeCare as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Addus HomeCare by 1.5% during the first quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after buying an additional 19,027 shares during the last quarter. Wellington Management Group LLP boosted its stake in Addus HomeCare by 1.2% during the fourth quarter. Wellington Management Group LLP now owns 798,435 shares of the company’s stock valued at $74,135,000 after buying an additional 9,548 shares during the last quarter. Point72 Asset Management L.P. boosted its stake in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 20.9% in the 2nd quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock valued at $49,979,000 after purchasing an additional 74,488 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling

In related news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 in the last ninety days. 4.60% of the stock is owned by insiders.

Addus HomeCare Trading Down 3.2 %

Shares of NASDAQ:ADUS opened at $128.72 on Wednesday. Addus HomeCare Co. has a 12-month low of $78.35 and a 12-month high of $136.12. The business’s fifty day simple moving average is $128.48 and its 200-day simple moving average is $115.67. The company has a market capitalization of $2.33 billion, a PE ratio of 31.94, a P/E/G ratio of 2.40 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the business posted $0.94 EPS. Research analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Macquarie assumed coverage on Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. Stephens reiterated an “overweight” rating and issued a $138.00 price target on shares of Addus HomeCare in a report on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $141.00 price target on shares of Addus HomeCare in a report on Tuesday, September 3rd. TD Cowen raised their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. One research analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $128.29.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.